LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 35

Search options

  1. Article ; Online: Strengthening the Medicaid Reentry Act - Supporting the Health of People Who Are Incarcerated.

    Khatri, Utsha G / Winkelman, Tyler N A

    The New England journal of medicine

    2022  Volume 386, Issue 16, Page(s) 1488–1490

    MeSH term(s) Delivery of Health Care/legislation & jurisprudence ; Health Status ; Humans ; Insurance Coverage/legislation & jurisprudence ; Medicaid/legislation & jurisprudence ; Prisoners ; United States
    Language English
    Publishing date 2022-01-26
    Publishing country United States
    Document type Journal Article
    ZDB-ID 207154-x
    ISSN 1533-4406 ; 0028-4793
    ISSN (online) 1533-4406
    ISSN 0028-4793
    DOI 10.1056/NEJMp2119571
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: EMR Stalking.

    Khatri, Utsha G

    Academic emergency medicine : official journal of the Society for Academic Emergency Medicine

    2017  Volume 25, Issue 6, Page(s) 708

    Language English
    Publishing date 2017-11-03
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1329813-6
    ISSN 1553-2712 ; 1069-6563
    ISSN (online) 1553-2712
    ISSN 1069-6563
    DOI 10.1111/acem.13320
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Aligning Correctional Health Standards With Medicaid-Covered Benefits.

    Olson, Marin G / Khatri, Utsha G / Winkelman, Tyler N A

    JAMA health forum

    2020  Volume 1, Issue 7, Page(s) e200885

    Language English
    Publishing date 2020-07-01
    Publishing country United States
    Document type Journal Article
    ISSN 2689-0186
    ISSN (online) 2689-0186
    DOI 10.1001/jamahealthforum.2020.0885
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: State level variation in substance use treatment admissions among criminal legal-referred individuals.

    Shearer, Riley D / Winkelman, Tyler N A / Khatri, Utsha G

    Drug and alcohol dependence

    2022  Volume 240, Page(s) 109651

    Abstract: Background: Individuals involved in the criminal legal system face unique challenges to accessing substance use disorder (SUD) treatment, yet state-level variation in referrals for treatment remains largely unknown. To address disparities in the ... ...

    Abstract Background: Individuals involved in the criminal legal system face unique challenges to accessing substance use disorder (SUD) treatment, yet state-level variation in referrals for treatment remains largely unknown. To address disparities in the overdose crisis among individuals with criminal legal involvement, it is important to understand variation in SUD treatment across states.
    Methods: We conducted a retrospective comparison of substance use treatment referrals from the criminal legal system and other sources across participating states. Using data from the 2018-2019 Treatment Episode Dataset-Admissions, we characterized treatment referral rates from the criminal legal system, the substances most commonly leading to treatment, and rates of treatment with medication for opioid use disorder (MOUD) across states.
    Results: Across all states, criminal legal referral rates were higher than non-criminal legal rates. Criminal-legal referral rates, adjusted for state overdose deaths, were highest in the Northeast and Midwest. Methamphetamine use was the most common substance leading to treatment referral from the criminal legal system in 24 states while opioid use was the most common reason for non-criminal legal referrals in 34 states. In over half the states analyzed, fewer than 10% of opioid treatment referrals from the criminal legal system received MOUD. In almost all states, MOUD was more common in treatment referred from non-criminal legal settings.
    Conclusion: State-specific policies and practices shape drug policy and the SUD treatment landscape for people with criminal legal involvement. Standards and ongoing monitoring for substance use treatment referrals from the criminal-legal system should be considered by federal agencies charged with addressing the ongoing overdose crisis.
    MeSH term(s) Humans ; United States/epidemiology ; Analgesics, Opioid/therapeutic use ; Retrospective Studies ; Opioid-Related Disorders/therapy ; Opioid-Related Disorders/drug therapy ; Drug Overdose/therapy ; Drug Overdose/drug therapy ; Referral and Consultation ; Methamphetamine ; Opiate Substitution Treatment ; Buprenorphine/therapeutic use
    Chemical Substances Analgesics, Opioid ; Methamphetamine (44RAL3456C) ; Buprenorphine (40D3SCR4GZ)
    Language English
    Publishing date 2022-10-01
    Publishing country Ireland
    Document type Journal Article
    ZDB-ID 519918-9
    ISSN 1879-0046 ; 0376-8716
    ISSN (online) 1879-0046
    ISSN 0376-8716
    DOI 10.1016/j.drugalcdep.2022.109651
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Opioid Use Disorder and COVID-19: Crashing of the Crises.

    Khatri, Utsha G / Perrone, Jeanmarie

    Journal of addiction medicine

    2020  Volume 14, Issue 4, Page(s) e6–e7

    Abstract: The COVID19 crisis has created many additional challenges for patients with opioid use disorder, including those seeking treatment with medications for OUD. Some of these challenges include closure of substance use treatment clinics, focus of emergency ...

    Abstract : The COVID19 crisis has created many additional challenges for patients with opioid use disorder, including those seeking treatment with medications for OUD. Some of these challenges include closure of substance use treatment clinics, focus of emergency departments on COVID-19 patients, social distancing and shelter in place orders affecting mental health, bystander overdose rescue, threats to income and supply of substances for people who use drugs. While the initial changes in regulation allowing buprenorphine prescribing by telehealth are welcomed by providers and patients, many additional innovations are required to ensure that additional vulnerabilities and hurdles created by this pandemic scenario do not further fan the flames of the opioid epidemic.
    MeSH term(s) Betacoronavirus ; COVID-19 ; Coronavirus Infections/epidemiology ; Coronavirus Infections/prevention & control ; Health Services Accessibility/organization & administration ; Humans ; Infection Control/organization & administration ; Narcotic Antagonists/therapeutic use ; Opiate Substitution Treatment/methods ; Opioid-Related Disorders/drug therapy ; Opioid-Related Disorders/epidemiology ; Opioid-Related Disorders/psychology ; Organizational Innovation ; Pandemics/prevention & control ; Pneumonia, Viral/epidemiology ; Pneumonia, Viral/prevention & control ; SARS-CoV-2 ; Telemedicine/organization & administration ; United States
    Chemical Substances Narcotic Antagonists
    Keywords covid19
    Language English
    Publishing date 2020-05-11
    Publishing country United States
    Document type Journal Article
    ISSN 1935-3227
    ISSN (online) 1935-3227
    DOI 10.1097/ADM.0000000000000684
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Considering the harms of our habits: The reflexive urine drug screen in opioid use disorder treatment.

    Khatri, Utsha G / Aronowitz, Shoshana V

    Journal of substance abuse treatment

    2020  Volume 123, Page(s) 108258

    Abstract: The COVID-19 pandemic has led to abrupt changes in the delivery of substance use treatment, notably the adoption of telehealth services and a departure from mandatory urine drug screens (UDS). Amid current circumstances, the UDS, which had evolved to ... ...

    Abstract The COVID-19 pandemic has led to abrupt changes in the delivery of substance use treatment, notably the adoption of telehealth services and a departure from mandatory urine drug screens (UDS). Amid current circumstances, the UDS, which had evolved to signal a "successful" recovery, no longer seems feasible, safe, or necessary. Even prior to the pandemic, the UDS had notable drawbacks, including sending a message of mistrust and hierarchy, potentially causing psychological trauma, and incentivizing falsification. Nonetheless, certain patients may state that they depend on the UDS for motivation or structure while some providers may rely on it to discover which patients are struggling. While a combination of self-report and UDS is generally regarded as the strongest measure of substance use among patients, our experiences caring for patients without the results of the UDS during the COVID-19 pandemic have forced us to examine the use of other measures to define a successful recovery. Complete abstinence may not be the goal for all patients and those who achieve abstinence may have additional goals worth supporting. While the UDS will likely be incorporated back into our treatment plans, we suggest unseating it as the centerpiece of substance use care and discovering additional methods of measuring our patients' outcomes in less traumatizing and more patient-centered ways.
    MeSH term(s) COVID-19 ; Humans ; Opioid-Related Disorders/diagnosis ; Pandemics ; SARS-CoV-2 ; Self Report ; Substance Abuse Detection ; United States ; Urinalysis
    Language English
    Publishing date 2020-12-20
    Publishing country United States
    Document type Journal Article
    ZDB-ID 605923-5
    ISSN 1873-6483 ; 0740-5472
    ISSN (online) 1873-6483
    ISSN 0740-5472
    DOI 10.1016/j.jsat.2020.108258
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Treatment setting among individuals with opioid use and criminal legal involvement, housing instability, or Medicaid insurance, 2015-2021.

    Shearer, Riley D / Howell, Benjamin A / Khatri, Utsha G / Winkelman, Tyler N A

    Drug and alcohol dependence reports

    2023  Volume 8, Page(s) 100179

    Abstract: Background: Individuals with criminal legal involvement (CLI), housing instability, or Medicaid insurance may experience barriers accessing substance use treatment in certain settings. Previous research has found individuals in these groups are less ... ...

    Abstract Background: Individuals with criminal legal involvement (CLI), housing instability, or Medicaid insurance may experience barriers accessing substance use treatment in certain settings. Previous research has found individuals in these groups are less likely to receive medications for opioid use disorder (MOUD), but the role treatment setting may play in low rates of MOUD is unclear.
    Methods: We conducted a cross-sectional study using nationally representative survey data from 2015 to 2021. We estimated the proportion of individuals who had CLI, housing instability, or Medicaid insurance who received substance use treatment in a variety of settings. We used multivariable logistic regressions to estimate the associations between group and the receipt of MOUD across treatment settings.
    Results: Individuals with CLI, housing instability, or Medicaid insurance were more likely to receive substance use treatment in hospitals, rehabilitation, and mental health facilities compared with individuals not in these groups. However, all groups accessed substance use treatment in doctors' offices at similar rates. Treatment at a doctor's office was associated with the highest likelihood of receiving MOUD (aOR 4.73 [95% CI: 2.2.15-10.43]). Across multiple treatment settings, Individuals with CLI or housing instability were less likely to receive MOUD.
    Conclusions: Individuals with CLI, housing instability, or Medicaid insurance are more likely to access substance use treatment at locations associated with lower rates of MOUD use. MOUD access across treatment settings is needed to improve engagement and retention in treatment for patients experiencing structural disadvantage or who have low incomes.
    Language English
    Publishing date 2023-07-12
    Publishing country Netherlands
    Document type Journal Article
    ISSN 2772-7246
    ISSN (online) 2772-7246
    DOI 10.1016/j.dadr.2023.100179
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Buprenorphine Telehealth Treatment Initiation and Follow-Up During COVID-19.

    Samuels, Elizabeth A / Khatri, Utsha G / Snyder, Hannah / Wightman, Rachel S / Tofighi, Babak / Krawczyk, Noa

    Journal of general internal medicine

    2022  Volume 37, Issue 5, Page(s) 1331–1333

    MeSH term(s) Buprenorphine/therapeutic use ; COVID-19 ; Follow-Up Studies ; Humans ; Opiate Substitution Treatment ; Opioid-Related Disorders/drug therapy ; Telemedicine
    Chemical Substances Buprenorphine (40D3SCR4GZ)
    Language English
    Publishing date 2022-01-03
    Publishing country United States
    Document type Research Support, U.S. Gov't, P.H.S. ; Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, N.I.H., Extramural
    ZDB-ID 639008-0
    ISSN 1525-1497 ; 0884-8734
    ISSN (online) 1525-1497
    ISSN 0884-8734
    DOI 10.1007/s11606-021-07249-8
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Treatment setting among individuals with opioid use and criminal legal involvement, housing instability, or Medicaid insurance, 2015-2021

    Riley D. Shearer / Benjamin A. Howell / Utsha G. Khatri / Tyler N.A. Winkelman

    Drug and Alcohol Dependence Reports, Vol 8, Iss , Pp 100179- (2023)

    2023  

    Abstract: Background: Individuals with criminal legal involvement (CLI), housing instability, or Medicaid insurance may experience barriers accessing substance use treatment in certain settings. Previous research has found individuals in these groups are less ... ...

    Abstract Background: Individuals with criminal legal involvement (CLI), housing instability, or Medicaid insurance may experience barriers accessing substance use treatment in certain settings. Previous research has found individuals in these groups are less likely to receive medications for opioid use disorder (MOUD), but the role treatment setting may play in low rates of MOUD is unclear. Methods: We conducted a cross-sectional study using nationally representative survey data from 2015 to 2021. We estimated the proportion of individuals who had CLI, housing instability, or Medicaid insurance who received substance use treatment in a variety of settings. We used multivariable logistic regressions to estimate the associations between group and the receipt of MOUD across treatment settings. Results: Individuals with CLI, housing instability, or Medicaid insurance were more likely to receive substance use treatment in hospitals, rehabilitation, and mental health facilities compared with individuals not in these groups. However, all groups accessed substance use treatment in doctors’ offices at similar rates. Treatment at a doctor's office was associated with the highest likelihood of receiving MOUD (aOR 4.73 [95% CI: 2.2.15-10.43]). Across multiple treatment settings, Individuals with CLI or housing instability were less likely to receive MOUD. Conclusions: Individuals with CLI, housing instability, or Medicaid insurance are more likely to access substance use treatment at locations associated with lower rates of MOUD use. MOUD access across treatment settings is needed to improve engagement and retention in treatment for patients experiencing structural disadvantage or who have low incomes.
    Keywords Criminal legal involvement ; Homelessness ; Opioid use disorder ; MOUD ; Substance use treatment ; Medicine ; R
    Subject code 360
    Language English
    Publishing date 2023-09-01T00:00:00Z
    Publisher Elsevier
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  10. Article ; Online: Medicaid Expansion Increased Medications For Opioid Use Disorder Among Adults Referred By Criminal Justice Agencies.

    Khatri, Utsha G / Howell, Benjamin A / Winkelman, Tyler N A

    Health affairs (Project Hope)

    2021  Volume 40, Issue 4, Page(s) 562–570

    Abstract: Individuals involved with the US criminal justice system have high rates of opioid use disorder (OUD) but face significant barriers to evidence-based treatment. Using 2008-17 data from the Treatment Episode Data Set-Admissions, we examined trends in ... ...

    Abstract Individuals involved with the US criminal justice system have high rates of opioid use disorder (OUD) but face significant barriers to evidence-based treatment. Using 2008-17 data from the Treatment Episode Data Set-Admissions, we examined trends in receipt of medications for OUD among individuals referred by criminal justice agencies and other sources both before and after Medicaid expansion. Individuals referred by criminal justice agencies were less likely to receive medications for OUD than were those referred by other sources during our study period, although this disparity narrowed slightly after Medicaid expansion. Receipt of medications for OUD increased more for individuals referred by criminal justice agencies in states that expanded Medicaid compared with those in states that did not. Medicaid expansion may improve evidence-based treatment for individuals with criminal justice involvement and OUD, although additional policy change outside the health care sector is likely needed to reduce persistent treatment disparities.
    MeSH term(s) Adult ; Criminal Law ; Hospitalization ; Humans ; Medicaid ; Opiate Substitution Treatment ; Opioid-Related Disorders/drug therapy ; Referral and Consultation ; United States
    Language English
    Publishing date 2021-04-05
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 632712-6
    ISSN 1544-5208 ; 0278-2715
    ISSN (online) 1544-5208
    ISSN 0278-2715
    DOI 10.1377/hlthaff.2020.01251
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top